---
title: 'CCRE Module for DNA KEY: Phased Development Blueprint'
slug: ccre-module-for-dna-key-phased-development-blueprint
status: draft
created: '2026-03-20'
updated: '2026-03-20'
version: 0.1.0
tags:
- multiplicity
traceability:
  path: 05-systems/engines/ccre/CCRE Module Blueprint.md
  last_synced: '2026-03-20T17:17:18.321356Z'
---

# CCRE Module for DNA KEY: Phased Development Blueprint

## Foundational Definitions

**CCRE** (Certified Computational Refinement Engine) is the ADR-004 somatic hypermutation layer within the INTRINSICA AI System. It performs bounded parametric refinement under fixed structure, reusing CRMF's contraction certificate and drift bounds rather than introducing a new gate.[^1][^2]

**Ownership**: CCRE is CHL-owned IP on the same terms as CRMF — an Improvement and derivative work created by Dr. Van Gelder in CHL capacity, within the DNA KEY / INTRINSICA field of use. CHL controls patent rights, licensing, and trade-secret boundaries.[^2][^1]

**Architectural Position**: CCRE sits between CRMF and ACFL in the ECP pipeline:

```
Input Sources → WKD → CRMF → CCRE (ADR-004) → ACFL → HITL → Output
```

Within the 5-domain architecture, CCRE is embedded inside Domain 140 (INTRINSICA AI System) as the adaptive learning mechanism that refines ACFL parameters based on HITL practitioner feedback while preserving CRMF stability bounds. It is not a separate domain or gate.[^1]

***

## Phase 0: Governance Lock (Days 1–7)

### Objective
Establish ownership, formal definition, and IP position before any code is written.

### Detailed Instructions

**0A. IP Position Memo (Day 1–2)**

Draft and sign a one-paragraph board-level IP position memo:

> "CCRE is a CRMF-derived refinement operator, created in CHL capacity, owned and controlled by CHL on the same terms as CRMF within the DNA KEY / INTRINSICA field-of-use. CCRE operates as the bounded parametric refinement module implementing somatic-hypermutation-style updates under CRMF's contraction certificate and drift guard (Theorem 4.3)."[^2][^1]

- **Owner**: CHL principals (JCR, CV)
- **Metric**: Signed email or board minute on record
- **Horizon**: 48 hours

**0B. Canonical Definition Freeze (Day 1–3)**

Lock the CCRE definition in the specification glossary. The canonical sentence:

> "In the context of DNA KEY, the Certified Computational Refinement Engine (CCRE) denotes the bounded parametric refinement module that implements somatic-hypermutation-style parameter updates under the contraction certificate (κ < 1) and drift guard (δ < 0.3) established by CRMF Theorem 4.3."[^2]

This definition must appear in:
- R4B patent specification glossary
- Internal architecture decision record (ADR-004)
- ECP Phase 1 protocol documentation

**0C. Notation and Symbol Registry (Day 2–3)**

| Symbol | Meaning |
|--------|---------|
| κ | Contraction coefficient (must remain < 1) |
| δ | Semantic drift bound (must remain < 0.3) |
| α | Lipschitz constant (default 0.3, stability if α < 0.05) |
| R(t) | Resonance functional at time t |
| J | Jubilee period (audit cycle length) |
| FREEZE→RESONANCE | Fail-closed state when bounds exceeded |

These symbols must be used consistently across all CCRE documents.[^1][^2]

**0D. ADR-004 Formal Registration (Day 3–7)**

Create the Architecture Decision Record for CCRE:
- **Status**: Accepted
- **Context**: The ECP pipeline requires adaptive parameter refinement without compromising CRMF stability guarantees
- **Decision**: CCRE implements parameter-only learning under enforced Lipschitz/drift caps. Structural changes are reserved for ADR-005 with explicit human gate
- **Consequences**: All parameter updates must pass the four-gate predicate. CCRE cannot modify operator structure, model architecture, or gate thresholds[^1]

***

## Phase 1: Mathematical Foundation (Weeks 1–3)

### Objective
Formally prove that CCRE's update mechanism preserves all CRMF invariants, producing the specification section required for 112 enablement.

### Detailed Instructions

**1A. Contraction Preservation Proof (Week 1)**

Prove: If the CRMF state \(\Phi\) satisfies \(\kappa(\Phi) < 1\) before a CCRE update, and the update is restricted to parameter modifications within the Lipschitz ball of radius \(\epsilon\), then \(\kappa(\Phi') < 1\) after the update.[^2]

The proof structure:
1. Define the CCRE update operator \(U: \theta \mapsto \theta'\) where \(\theta\) is the parameter vector
2. Show \(U\) is itself a contraction: \(\|U(\theta_1) - U(\theta_2)\| \leq \lambda \|\theta_1 - \theta_2\|\) with \(\lambda < 1\)
3. Apply Theorem 4.3: the composed system \(\Phi \circ U\) inherits the fixed-point guarantee since \(\alpha \cdot \lambda < 1\) when both factors are contractions[^2]

- **Owner**: Lead MT (RVG)
- **Metric**: Written proof, ≤ 5 pages
- **Horizon**: 5 days

**1B. Drift Bound Preservation Proof (Week 1–2)**

Prove: CCRE parameter updates maintain \(\delta < 0.3\) where drift is computed via SBERT cosine similarity between pre-update and post-update semantic embeddings.[^2]

Key elements:
- Define the drift function: \(\delta(t) = 1 - \cos(\text{SBERT}(S_t), \phi_{\text{basis}})\)
- Show that parameter-only updates (no structural changes) produce bounded semantic drift: \(\delta(\theta') - \delta(\theta) \leq L_\delta \cdot \|\theta' - \theta\|\) where \(L_\delta\) is the Lipschitz constant of the drift function
- Derive the maximum step size \(\epsilon_{\max}\) such that \(\delta\) remains below 0.3 after any single update

This directly connects to the DriftTracker module and driftCheck.circom Groth16 proof pipeline.[^2]

- **Owner**: Lead MT (RVG)
- **Metric**: Proof with explicit ε_max formula
- **Horizon**: 7 days

**1C. Resonance Gate Compatibility (Week 2)**

Prove: CCRE updates do not trigger spurious FREEZE→RESONANCE events. Specifically:
- Show that if \(R(t) \in [R_{\min}, R_{\text{safe}}]\) before update, then \(R(t') \in [R_{\min}, R_{\text{safe}}]\) after update, provided the update stays within the Lipschitz ball
- Derive the relationship between update magnitude and resonance perturbation[^1][^2]

The enhanced CSC algorithm with resonance already provides the template:
```
if R(t) < R_min or R(t) > R_safe:
    status = "FREEZE→RESONANCE"
    m = 0  # Fail-closed
```

CCRE must never push R(t) outside the safe band.[^2]

- **Owner**: Lead MT (RVG)
- **Metric**: Compatibility theorem with worked example
- **Horizon**: 10 days

**1D. Clonal Selection Formalization (Week 2–3)**

Formalize the mechanism by which CCRE selects among candidate parameter updates (the "clonal selection" enhancement from the AGI immune system analogy):

- Candidate contraction certificates from ADR-004 mutations are collected in a bounded buffer of size N
- Sorted by verified κ value
- Minimum κ selected: \(C^* = C_i : K(C_i) = \min\{K(C_j)\} \text{ s.t. } \text{Auth}(C_j) = \text{true}\)
- Buffer overflow triggers L1 escalation (adaptive immune activation)
- Convergence rate: \(K_n = O(n^{-1/2})\) over Jubilee cycles n[^1]

- **Owner**: Lead MT (RVG)
- **Metric**: Selection operator definition with convergence proof
- **Horizon**: 14 days

***

## Phase 2: Core Implementation (Weeks 3–8)

### Objective
Build the reference implementation of CCRE as a Python module integrated with the existing INTRINSICA codebase.

### Detailed Instructions

**2A. CCRE Core Module (Weeks 3–5)**

Build the CCRE Python package:

```
ccre/
├── __init__.py
├── updater.py          # Core parameter update logic
├── contraction.py      # Contraction certificate verification
├── drift_tracker.py    # SBERT-based drift monitoring
├── resonance_guard.py  # Resonance bound enforcement
├── clonal_selector.py  # Candidate selection buffer
├── witness.py          # CRMF witness object emission
├── safety.py           # FREEZE→RESONANCE trigger logic
└── tests/
    ├── test_contraction.py
    ├── test_drift.py
    ├── test_resonance.py
    ├── test_clonal.py
    └── test_safety.py
```

**updater.py** — Core update logic:
- Accept current parameter vector θ, proposed update Δθ, and current CRMF state
- Compute proposed θ' = θ + Δθ
- Verify ‖Δθ‖ ≤ ε_max (from Phase 1B proof)
- Request contraction certificate for θ'
- If κ(θ') < 1 and δ(θ') < 0.3 and R(t') ∈ [R_min, R_safe]: apply update
- Otherwise: reject update, log rejection reason, emit EXECUTION→SILENT event

**contraction.py** — Certificate verification:
- Compute κ for proposed state using the CRMF C6 axiom machinery[^2]
- Verify κ < 1 (strict contraction)
- Emit machine-checkable certificate: `{lipschitz_bound, norm_used, verification_hash, R(t), κ(t), status}`

**drift_tracker.py** — Semantic drift monitoring:
- Compute drift via SBERT cosine distance: `computeDrift(S_t, phi_basis)`[^2]
- Export to driftCheck.circom for Groth16 proof generation
- Maintain drift history for L2 audit

**resonance_guard.py** — Resonance bound enforcement:
- Monitor R(t) against [R_min, R_safe] bounds
- Implement the resonance modulation tier from the enhanced CSC algorithm
- Trigger FREEZE→RESONANCE when bounds exceeded, setting update magnitude to 0[^2]

**clonal_selector.py** — Candidate selection:
- Bounded buffer of size N (configurable, default N=16)
- Sort candidates by verified κ
- Select minimum κ with Auth(C) = true
- Overflow → L1 escalation[^1]

**witness.py** — CRMF witness object emission:
- Every CCRE update emits a deterministic witness: `{transform_id, input_hash, output_hash, parameters, certificate}`
- Witness is Merkle-linked into the DNA KEY audit trail
- Wrapped in AuditEvent of type XI→STATE_TRANSITION[^2]

- **Owner**: CTO / Eng Lead
- **Metric**: All modules implemented with passing unit tests
- **Horizon**: 3 weeks

**2B. Monitoring Hierarchy Integration (Weeks 5–6)**

Integrate CCRE with the L0/L1/L2/L2.5 monitoring hierarchy:[^1]

| Level | Check | Frequency | CCRE Integration |
|-------|-------|-----------|------------------|
| L0 | C_commutator, W_staleness, D_velocity, B_budget | Every cycle, O(1) | CCRE updates increment cycle counter; L0 checks run post-update |
| L1 | D_tensor > 1 | On threshold breach | CCRE drift > 0.3 triggers L1 activation |
| L2 | Var(κ) audit | Every J periods | Audit CCRE update history for κ oscillation |
| L2.5 | Var(κ) > 2σ | On L2 detection | Freeze CCRE, revert to last Jubilee-verified configuration |

Implementation requirements:
- L0 invariant checks must run in O(1) time per CCRE update cycle
- L1 threshold must be configurable but default to D_tensor > 1
- L2 audits Var(κ) over a sliding window of 2J periods
- L2.5 implements the regulatory suppression layer: freeze current CCRE parameters, revert to Jubilee checkpoint, log reversion event[^1]

- **Owner**: CTO
- **Metric**: Monitoring integration test suite passing; L2.5 reversion verified against synthetic oscillation scenarios
- **Horizon**: 2 weeks

**2C. PW-CFL Integration Layer (Weeks 6–8)**

CCRE refines parameters for the aggregation engine. With PW-CFL now replacing generic ACFL operators, CCRE must be aware of the positionally-weighted structure:[^3]

- CCRE parameter updates may adjust PW-CFL predicate assignments (which input position gets which prime weight)
- CCRE must preserve PW-CFL axioms PW1–PW7 across updates (compensation, equivariance, strict monotonicity, veto, reciprocity, transitivity, De Morgan)
- The 42.4% maximum divergence from commutative operators means CCRE position-reassignment decisions have large downstream effects — updates must be bounded more tightly than for commutative operators

Implementation:
- Add PW-CFL axiom verification to the CCRE post-update check pipeline
- Log pre/post PW-CFL conjunction values for audit
- Restrict position reassignment to L2 audit cycles (not every update)

- **Owner**: Lead MT + CTO
- **Metric**: PW-CFL axiom verification passing after CCRE updates; position reassignment bounded to J-cycle frequency
- **Horizon**: 2 weeks

***

## Phase 3: Safety Validation (Weeks 6–10)

### Objective
Prove CCRE cannot worsen system behavior under any operating condition.

### Detailed Instructions

**3A. ENVELOPESAFEBUTDIVERGING Simulation (Week 6–7)**

Inject controlled divergence into a test harness:[^1]
- Test cases: κ = 1.01, 1.05, 1.1
- Measure actual detection latency against predicted 1/(κ−1) formula
- For κ = 1.01 and ε = 0.01: predicted detection within 462 cycles
- Verify CCRE enters FREEZE→RESONANCE within predicted window

The existing ADR-001 test suite has 1,111 passing tests. Extend this infrastructure:
- 50 new test cases for CCRE-specific divergence injection
- 20 test cases for cascading failure (CCRE divergence → L1 → L2 escalation)
- 10 test cases for L2.5 regulatory suppression recovery

- **Owner**: CTO / Eng Lead
- **Metric**: Detection latency within 2× predicted for all injection scenarios; zero undetected divergences
- **Horizon**: 2 weeks

**3B. Adversarial Confidence Testing (Weeks 7–8)**

Replace the i.i.d. confidence accumulator with the Markov chain correction:[^1]

\[
\text{conf}(s, k) = 1 - \prod_{i=1}^{k}(1 - P_{\text{detect}}(s, i \mid H_{i-1}))
\]

where \(P_{\text{detect},i}\) depends on the previous patrol outcome through a transition kernel.

Test protocol:
- Generate correlated state corruption sequences (simulating adversarial attack)
- Compare detection performance: i.i.d. model vs. Markov model
- Verify Markov model provides conservative (lower) confidence estimates under correlation

- **Owner**: Lead MT
- **Metric**: Markov model detection rate ≥ i.i.d. model under 5 adversarial correlation regimes
- **Horizon**: 2 weeks

**3C. Gate Independence Verification (Weeks 8–10)**

Formally verify that Gates 1 (Lipschitz bound) and 2 (contraction mapping) use structurally independent computation paths:[^1]

- Use static analysis (TLA+ or Alloy model checking) on the CCRE codebase
- Prove the σ-algebras generated by Gate 1 and Gate 2 computations are independent conditioned on the input
- This is the highest-priority safety validation — the cytokine storm detection guarantee depends on it

- **Owner**: CTO + external verification consultant
- **Metric**: Formal independence proof or identified shared state with remediation
- **Horizon**: 3 weeks

**3D. Regression Suite (Weeks 8–10)**

Build the comprehensive CCRE regression suite:
- No new ENVELOPESAFEBUTDIVERGING states after CCRE integration
- No increase in L2 autoimmune variance (Var(κ) stable or decreasing)
- All 12 acceptance tests from the CRMF-ΛProof specification pass with CCRE active:[^2]

| Test | Description | CCRE-Specific Requirement |
|------|-------------|--------------------------|
| 1 | Silent Mode | CCRE drift > 0.3 → EXECUTION→SILENT |
| 2 | No PHI | CCRE witness objects contain only hashes |
| 3 | Replay | CCRE update nullifiers prevent replay |
| 4 | CRMF determinism | Same input + same CCRE state → identical witness hash |
| 5 | CRMF stability | Uncertified (κ ≥ 1) CCRE updates fail closed |
| 6 | Resonance gate | R(t) outside bounds → FREEZE→RESONANCE, update = 0 |
| 7 | Trait proof | CCRE parameters not exposed in trait proofs |
| 8 | Attestation binding | CCRE witness root included in recommendation digest |
| 9 | Ξ-Certification | All 10 critiques pass after CCRE update |
| 10 | Capability Token | CCRE updates bound to valid Capability Token |
| 11 | Merkle checkpoint | CCRE events verifiable via Merkle proof |
| 12 | Drift compliance | DriftTracker → driftCheck.circom → Groth16 proof |

- **Owner**: CTO / Eng Lead
- **Metric**: 12/12 acceptance tests passing; regression suite green
- **Horizon**: 3 weeks

***

## Phase 4: ECP Pilot Instrumentation (Weeks 8–14)

### Objective
Instrument the ECP Phase 1 pilot to generate the empirical evidence an examiner will require: CCRE-on vs. CCRE-off performance across five domains.[^1][^2]

### Detailed Instructions

**4A. Pilot Protocol Design (Weeks 8–9)**

Design the CCRE evaluation protocol within ECP Phase 1:

- **Population**: First 50–100 patients or 90 days, whichever comes first[^1]
- **Design**: CCRE-on vs. CCRE-off epochs (alternating or randomized blocks)
- **Five domains measured**:

| Domain | Metric | CCRE-On Target | CCRE-Off Baseline |
|--------|--------|----------------|-------------------|
| PT-EPI | Phase transition prediction accuracy | AUROC ≥ 0.90 | AUROC baseline |
| ROS | Antioxidant intervention timing | Brier score improvement ≥ 5% | Brier baseline |
| CRMF | Stability certificate quality | κ mean decrease | κ baseline |
| ACFL/PW-CFL | Predicate evaluation accuracy | Practitioner agreement ≥ 90% | Agreement baseline |
| Closed Loop | Intervention-to-outcome latency | Reduction ≥ 10% | Latency baseline |

- **Safety constraints logged every cycle**: κ < 1, δ < 0.3, R(t) ∈ [R_min, R_safe]
- **Success criteria**: ≥1 statistically significant improvement per domain AND zero certified-violation events[^1]

- **Owner**: Eureka Analytics Lead
- **Metric**: Protocol document approved by all stakeholders
- **Horizon**: 2 weeks

**4B. Instrumentation Implementation (Weeks 9–11)**

Build the CCRE logging infrastructure:

- **Update log**: Every CCRE parameter update recorded with timestamp, pre/post θ, pre/post κ, pre/post δ, R(t), approval status
- **Performance log**: Domain-specific metrics computed pre/post each CCRE update epoch
- **Safety log**: Continuous monitoring of all constraint bounds
- **Witness chain**: Every CCRE update emits a CRMF witness object Merkle-linked to the audit trail[^2]

Data pipeline:
```
CCRE Update → Witness Object → AuditEvent(XI→STATE_TRANSITION) 
→ Merkle Checkpoint → Hyperledger Fabric → Λ-Trace anchor
```

- **Owner**: Eng Lead
- **Metric**: Logging pipeline deployed, validated against synthetic workload
- **Horizon**: 3 weeks

**4C. Statistical Analysis Plan (Weeks 10–12)**

Pre-register the analysis plan:
- Primary analysis: Paired t-test or Wilcoxon signed-rank for CCRE-on vs. CCRE-off per domain
- Secondary analysis: Mixed-effects model accounting for patient-level variation
- Safety analysis: One-sided test confirming κ < 1 and δ < 0.3 hold in 100% of CCRE-on cycles
- Multiple comparison correction: Bonferroni across 5 domains (α = 0.01 per domain)
- Minimum detectable effect: 0.05 AUROC improvement at 80% power

- **Owner**: Lead MT + Eureka Analytics
- **Metric**: Pre-registered analysis plan (OSF or equivalent)
- **Horizon**: 2 weeks

**4D. Pilot Execution (Weeks 12–24+)**

Run the ECP Phase 1 pilot with CCRE instrumentation active:
- First 50 patients: Conservative CCRE (small ε_max, N=4 candidate buffer)
- Patients 51–100: Standard CCRE (production ε_max, N=16 buffer)
- Continuous safety monitoring with automatic halt if any constraint violation detected
- Interim analysis at 50 patients to confirm no safety signals before expansion

- **Owner**: ECP Program Lead
- **Metric**: Pilot report with per-domain delta-AUROC/Brier and zero violations
- **Horizon**: 90 days from pilot launch

***

## Phase 5: IP Execution (Weeks 4–16, parallel track)

### Objective
Integrate CCRE into the R4B patent and protect all novel mechanisms.

### Detailed Instructions

**5A. R4B Claim Drafting (Weeks 4–6)**

Insert CCRE into the parent non-provisional as a dependent claim cluster:[^2][^1]

**Independent Claim (CCRE System)**:
> A computer-implemented method for adaptively refining parameters of a certified health prediction system, comprising:
> (a) receiving a current parameter vector θ and a contraction certificate certifying κ(θ) < 1;
> (b) generating one or more candidate parameter updates Δθ within a bounded Lipschitz ball of radius ε_max;
> (c) for each candidate, computing a proposed contraction coefficient κ(θ + Δθ) and semantic drift δ(θ + Δθ);
> (d) selecting the candidate with minimum κ from those satisfying κ < 1, δ < 0.3, and R(t) ∈ [R_min, R_safe];
> (e) applying the selected update and emitting a deterministic witness object Merkle-linked to an audit trail;
> wherein the method preserves the stability guarantee of Theorem 4.3 across all updates.

**Dependent Claims**:
- Claim N+1: The method of Claim N, wherein candidate selection uses a bounded buffer of size N sorted by verified κ, with buffer overflow triggering escalation
- Claim N+2: The method of Claim N, wherein semantic drift is computed via sentence-transformer cosine distance and verified via zero-knowledge proof (Groth16)
- Claim N+3: The method of Claim N, wherein updates that violate any bound trigger a FREEZE→RESONANCE state with update magnitude set to zero (fail-closed)
- Claim N+4: The method of Claim N, wherein the system uses positionally-weighted compensatory fuzzy logic operators with prime-canonical weights, and parameter updates preserve permutation equivariance (PW-CFL integration)

- **Owner**: Patent Counsel + Lead MT
- **Metric**: Claim set reviewed for 112 sufficiency against Phase 1 proofs
- **Horizon**: 3 weeks

**5B. Examiner-Facing Evidence Package (Weeks 12–16)**

Compile the evidence package the examiner will evaluate:

1. **Theoretical guarantee**: Phase 1 proofs (contraction preservation, drift bound, resonance compatibility)
2. **Implementation evidence**: Phase 2 test suite results (12/12 acceptance tests)
3. **Safety evidence**: Phase 3 simulation results (divergence detection within predicted windows)
4. **Empirical evidence**: Phase 4 pilot interim results (delta-AUROC per domain)
5. **Unexpected results**: Quantified improvement with zero safety violations across N patients

The package must answer the examiner's overriding question: "Does this self-improving system actually improve, and can you prove it doesn't make things worse?"[^1]

Theory answers Part 1 (provably doesn't worsen). Pilot data answers Part 2 (actually improves).

- **Owner**: Patent Counsel + Lead MT
- **Metric**: Complete evidence package ready for filing or supplement
- **Horizon**: Week 16

**5C. Trade Secret Boundaries (Ongoing)**

CCRE-specific trade secrets to protect (not disclose in patent):

| Asset ID | Description | Protection |
|----------|-------------|------------|
| TS-19 | CCRE ε_max step size calibration | Server-side only, 5-person access |
| TS-20 | Clonal selection buffer size N and scoring weights | Encrypted config, quarterly audit |
| TS-21 | Domain-specific drift basis vectors (φ_basis) | Watermarked documents |
| TS-22 | Resonance safe band [R_min, R_safe] thresholds | Backend hard-coded, no config exposure |

These extend the existing TS-13 through TS-18 registry.[^2]

- **Owner**: Dir. IP Strategy
- **Metric**: TS registry updated, access controls verified
- **Horizon**: Before any filing

***

## Phase 6: Production Deployment (Weeks 14–24)

### Objective
Deploy CCRE in the production ECP pipeline with full monitoring and rollback capability.

### Detailed Instructions

**6A. Canary Deployment (Weeks 14–16)**

- Deploy CCRE to 5% of ECP traffic
- Monitor all safety bounds in real-time
- Automatic rollback if any κ ≥ 1 or δ ≥ 0.3 event detected
- 14-day canary period before expansion

**6B. Graduated Rollout (Weeks 16–20)**

- 5% → 25% → 50% → 100% over 4 weeks
- Each step requires:
  - Zero safety violations in previous step
  - L2 audit showing Var(κ) stable or decreasing
  - Practitioner feedback score ≥ 4.0/5.0

**6C. Production Monitoring (Weeks 20–24+)**

Continuous monitoring in production:

| Monitor | Frequency | Threshold | Action |
|---------|-----------|-----------|--------|
| κ check | Every CCRE cycle | κ ≥ 1 | FREEZE→RESONANCE, rollback |
| δ check | Every CCRE cycle | δ ≥ 0.3 | EXECUTION→SILENT, revert |
| R(t) check | Every CCRE cycle | Outside [R_min, R_safe] | FREEZE→RESONANCE |
| Var(κ) audit | Every J periods | Var(κ) > 2σ | L2.5 freeze and Jubilee revert |
| AUROC per domain | Weekly | Decrease > 0.02 | Alert, investigate |
| Practitioner agreement | Monthly | < 85% | Pause CCRE, review |

**6D. Jubilee Checkpoint System (Ongoing)**

Every J periods (configurable, default J = 7 days):
- Snapshot full CCRE parameter state
- Compute aggregate statistics: mean κ, max δ, domain AUROC
- Merkle-checkpoint the snapshot to Hyperledger Fabric
- Anchor to external chain (2-of-3 threshold: Bitcoin, Ethereum, Polygon)[^2]
- Jubilee snapshot becomes the revert target for L2.5 regulatory suppression

***

## Phase Mirror Dissonance

- CCRE is described as "bounded parametric refinement" but the boundary is only as strong as the enforcement. If ε_max is set too high, or the contraction check is approximate rather than exact, "bounded" becomes "theoretically bounded but practically unbounded." The proofs from Phase 1 must specify exact numerical bounds, not asymptotic guarantees.[^1]
- The ECP Phase 1 pilot is the evidence vehicle, but it ships wellness-only. If CCRE improvements are measured only in wellness-regime predictions (Stability Score, Entropy Export Score), the examiner may question whether CCRE demonstrates improvement in the diagnostic domains (PT-EPI, CRMF genomic) that the patent claims cover. The pilot metrics must map to the claim scope, not just the deployed scope.[^1][^2]
- CCRE's "clonal selection" mechanism selects the candidate with minimum κ. This optimizes for stability, not for prediction quality. A parameter update that maximally improves AUROC may not minimize κ. The selection operator needs a composite objective: minimize κ subject to AUROC improvement ≥ threshold. Without this, CCRE provably never worsens stability but may also never improve predictions.[^1]
- The PW-CFL integration adds a new failure mode. CCRE position-reassignment (changing which predicate gets which prime weight) produces up to 42.4% output divergence. A CCRE update that reassigns positions could appear as a massive drift event, triggering FREEZE→RESONANCE even when the reassignment is beneficial. The drift tracker must distinguish structural-reassignment drift from semantic-degradation drift.[^3]
- ADR-005 (structural evolution with human gate) is defined but not implemented. If CCRE parameter-only updates hit a ceiling where structural changes are needed, the system has no path forward except human intervention. This is correct by design but creates an operational bottleneck: who is the human, what is their SLA, and what happens to patients while waiting?[^1]

## Levers to Test Now

| Owner | Lever | Metric | Horizon |
|-------|-------|--------|---------|
| Lead MT (RVG) | Complete Phase 1 proofs: contraction preservation, drift bound, resonance compatibility. These gate everything else. | Three proofs, ≤ 15 pages total | 14 days |
| CTO / Eng Lead | Implement CCRE core module (updater.py through safety.py) with 12/12 acceptance tests passing | Test suite green, code reviewed | 5 weeks |
| Patent Counsel | Draft CCRE independent + 4 dependent claims for R4B, gated on Phase 1 proofs | Claim language reviewed for 112 sufficiency | 6 weeks |
| Eureka Analytics Lead | Instrument ECP Phase 1 for CCRE-on vs. CCRE-off across 5 domains | Pre-registered protocol with statistical analysis plan | 10 weeks |
| Dir. IP Strategy | Update TS registry with TS-19 through TS-22 for CCRE-specific trade secrets | Registry audited, access controls verified | 2 weeks |
| CTO | Define composite CCRE selection objective: min κ subject to AUROC improvement ≥ threshold, resolving the stability-vs-performance tension | Selection operator specification with worked example | 3 weeks |

## Optional Artifact

Checklist:
- Ownership locked: CCRE = CHL-owned CRMF improvement
- Function defined: ADR-004 bounded parametric refinement, not a gate
- Safety anchored: Contraction + drift + resonance bounds from Theorem 4.3
- Evidence designed: ECP Phase 1 CCRE-on vs. CCRE-off across 5 domains
- IP protected: Claims drafted, trade secrets registered, evidence package compiled
- Deployment governed: Canary → graduated → production with Jubilee checkpoints

## Precision Question

The composite selection objective (minimize κ subject to AUROC improvement ≥ threshold) creates a feasibility question: in how many CCRE update cycles will there exist at least one candidate in the buffer that simultaneously satisfies κ < 1, δ < 0.3, and AUROC improvement ≥ threshold? If the feasible set is frequently empty, CCRE will appear to "do nothing" for long stretches. The pilot must measure not just improvement magnitude but improvement frequency — what percentage of CCRE cycles produce an update that passes all constraints?

***

## Timeline Summary

| Phase | Weeks | Gate |
|-------|-------|------|
| 0 — Governance Lock | 0–1 | IP memo signed, ADR-004 registered |
| 1 — Mathematical Foundation | 1–3 | All preservation proofs complete |
| 2 — Core Implementation | 3–8 | Reference implementation with 12/12 tests |
| 3 — Safety Validation | 6–10 | Divergence simulation + gate independence verified |
| 4 — ECP Pilot Instrumentation | 8–14 (execution 12–24+) | Protocol registered, instrumentation deployed |
| 5 — IP Execution | 4–16, parallel | Claims drafted, evidence package compiled |
| 6 — Production Deployment | 14–24 | Canary → graduated → production |

Critical path: Phase 0 (governance) → Phase 1 (proofs) → Phase 2 (implementation) → Phase 3 (safety) → Phase 4 (pilot). Phases 5 and 6 parallelize around this spine. The single highest-risk item is the composite selection objective — without it, CCRE optimizes for stability at the expense of improvement, making the pilot evidence weak.

---

## References

1. [genomic-analogy-of-an-agi-immu-Kq_ceB_aQwuVUW6xp.LnmA.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_7fe074a6-5961-43e4-960e-64f41d4f7cde/b11ada63-a462-4349-81b8-7460bf1b9452/genomic-analogy-of-an-agi-immu-Kq_ceB_aQwuVUW6xp.LnmA.md?AWSAccessKeyId=ASIA2F3EMEYE5FOUOV35&Signature=BVIf5qCtIFzfsKA2eZRzzg5CKOM%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK7%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJHMEUCIQDKzU3UNroNmv3mcaoKzdGw%2FKMMQRZ7fZgkRIjOfIpN9wIgBzdbnF638i5NuLAxqpM83TlDnxd1KPCFNggMd5%2FawpEq8wQIdxABGgw2OTk3NTMzMDk3MDUiDNN1d1%2FFWwVc92IpdSrQBKXMeITMV6FqMDZWT2yUnuOU1Jqlr1yF3HuH5WF8lygvaxgeG3nxJ8jd3nXbfmxPK%2FORJYjP5GgF2pEurBuED7ZoL%2BTxiAxnKDZkwO76RbeaJK8bMfR54sn7%2Fiu3mtceCcRg83gQVrmjT1b1DZtp0hAX6qor3d1Wi%2F%2BcKy342joUkHgb0y23%2FwLLKEpnkob9fqnQ1gPRdZmDTh%2BPUUNmaRx%2FBeznTsF9RnWISCuynESq%2BhUAoDQXBMViH5jJCN0bnPBfrX4l%2Bykvv7zHpE55PL0aFQmQN%2BO8iPOY%2BymhDIJSglvV63y9qqjcOR34D6vr5q9UQmEzD2r2ZHKKXKD1IUtiXTseH1VnUkSEXIYZ7kxLrC13vgdrsFoOqnC17lxsNAsJBR9Rf6xmoB%2FTsZF2R4qqfHQ5PWXCbRERdx4xhPBqcP9urixcIq%2BtGRElje8yPoxv3I4pC6TKKoE96Cu1RN%2FeaVj79GqTSP2aabEnkAedX5FYDYCUPsdPODeZe4nHOywsDbJIoh2rCy8r0yTEYAMZ2yc2ereefM7Z6Tr4bn1nMk96oER%2B%2BQ7Q%2BHTS%2FBgVoTkQ2xovw22j5HOCAf1cZBNx7%2BX0CFMfk91vAkLzEjfJoxEBJQn3RNXp7lplXO8IqoDJK5A1mbAAA3j%2Bd%2B4tg385pvZfADmKrGJn51dsZrA3yFoYHo0AtAZS1NycjSIdjuHjQ6xg1ZJpdyrntx%2FAYmPX2QSkeltTO%2BYt%2B9EH2aE7EzvXkDDZPo5OWdgrzLYmo3O%2BOM3vmnDTKnYkKzFOJwww68zazAY6mAHKkZKOrnwUgNNKet3caXydfSxIvJGyL%2BhwxdiDLKobUbbU2%2FmslpHM1ARUFjghzs685sH%2BfdFkp7voGPKpngnm%2F8d7yNkslo0KCku2Hk%2FWFBHIdDHWagxjR4bJ3cEO1TjUEWkeI9Q6fwgwdaddmBKaqQ1ExPV2%2Fui9BniRN1Xi5VEjbWw%2ByzCoPHUvKSmEWfbYMhgegCvuXA%3D%3D&Expires=1771484596) - img srchttpsr2cdn.perplexity.aipplx-full-logo-primary-dark402x.png styleheight64pxmargin-right32px

2. [DNA-KEY-CRMF-LProof-1.pdf](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_7fe074a6-5961-43e4-960e-64f41d4f7cde/133574db-a2cd-427a-85b5-531e590d30bf/DNA-KEY-CRMF-LProof-1.pdf?AWSAccessKeyId=ASIA2F3EMEYE5FOUOV35&Signature=Gwve%2Bzf3ZGMON%2BYi0WYoN2Ia2Bk%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK7%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJHMEUCIQDKzU3UNroNmv3mcaoKzdGw%2FKMMQRZ7fZgkRIjOfIpN9wIgBzdbnF638i5NuLAxqpM83TlDnxd1KPCFNggMd5%2FawpEq8wQIdxABGgw2OTk3NTMzMDk3MDUiDNN1d1%2FFWwVc92IpdSrQBKXMeITMV6FqMDZWT2yUnuOU1Jqlr1yF3HuH5WF8lygvaxgeG3nxJ8jd3nXbfmxPK%2FORJYjP5GgF2pEurBuED7ZoL%2BTxiAxnKDZkwO76RbeaJK8bMfR54sn7%2Fiu3mtceCcRg83gQVrmjT1b1DZtp0hAX6qor3d1Wi%2F%2BcKy342joUkHgb0y23%2FwLLKEpnkob9fqnQ1gPRdZmDTh%2BPUUNmaRx%2FBeznTsF9RnWISCuynESq%2BhUAoDQXBMViH5jJCN0bnPBfrX4l%2Bykvv7zHpE55PL0aFQmQN%2BO8iPOY%2BymhDIJSglvV63y9qqjcOR34D6vr5q9UQmEzD2r2ZHKKXKD1IUtiXTseH1VnUkSEXIYZ7kxLrC13vgdrsFoOqnC17lxsNAsJBR9Rf6xmoB%2FTsZF2R4qqfHQ5PWXCbRERdx4xhPBqcP9urixcIq%2BtGRElje8yPoxv3I4pC6TKKoE96Cu1RN%2FeaVj79GqTSP2aabEnkAedX5FYDYCUPsdPODeZe4nHOywsDbJIoh2rCy8r0yTEYAMZ2yc2ereefM7Z6Tr4bn1nMk96oER%2B%2BQ7Q%2BHTS%2FBgVoTkQ2xovw22j5HOCAf1cZBNx7%2BX0CFMfk91vAkLzEjfJoxEBJQn3RNXp7lplXO8IqoDJK5A1mbAAA3j%2Bd%2B4tg385pvZfADmKrGJn51dsZrA3yFoYHo0AtAZS1NycjSIdjuHjQ6xg1ZJpdyrntx%2FAYmPX2QSkeltTO%2BYt%2B9EH2aE7EzvXkDDZPo5OWdgrzLYmo3O%2BOM3vmnDTKnYkKzFOJwww68zazAY6mAHKkZKOrnwUgNNKet3caXydfSxIvJGyL%2BhwxdiDLKobUbbU2%2FmslpHM1ARUFjghzs685sH%2BfdFkp7voGPKpngnm%2F8d7yNkslo0KCku2Hk%2FWFBHIdDHWagxjR4bJ3cEO1TjUEWkeI9Q6fwgwdaddmBKaqQ1ExPV2%2Fui9BniRN1Xi5VEjbWw%2ByzCoPHUvKSmEWfbYMhgegCvuXA%3D%3D&Expires=1771484596) - DNA KEY CRMF Proof By Ryan O. Van Gelder DNA KEY CRMF Proof Integrated Framework Ownership and Open-...

3. [i-postulate-that-the-software-zyhZx6n8R1mdNvR.abuOZA.md](https://ppl-ai-file-upload.s3.amazonaws.com/web/direct-files/collection_7fe074a6-5961-43e4-960e-64f41d4f7cde/8b7a9451-1bda-4632-950d-bc4c6d595a2b/i-postulate-that-the-software-zyhZx6n8R1mdNvR.abuOZA.md?AWSAccessKeyId=ASIA2F3EMEYE5FOUOV35&Signature=Yl0ktiwJ250otvUh5%2BpTlqq6V30%3D&x-amz-security-token=IQoJb3JpZ2luX2VjEK7%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLWVhc3QtMSJHMEUCIQDKzU3UNroNmv3mcaoKzdGw%2FKMMQRZ7fZgkRIjOfIpN9wIgBzdbnF638i5NuLAxqpM83TlDnxd1KPCFNggMd5%2FawpEq8wQIdxABGgw2OTk3NTMzMDk3MDUiDNN1d1%2FFWwVc92IpdSrQBKXMeITMV6FqMDZWT2yUnuOU1Jqlr1yF3HuH5WF8lygvaxgeG3nxJ8jd3nXbfmxPK%2FORJYjP5GgF2pEurBuED7ZoL%2BTxiAxnKDZkwO76RbeaJK8bMfR54sn7%2Fiu3mtceCcRg83gQVrmjT1b1DZtp0hAX6qor3d1Wi%2F%2BcKy342joUkHgb0y23%2FwLLKEpnkob9fqnQ1gPRdZmDTh%2BPUUNmaRx%2FBeznTsF9RnWISCuynESq%2BhUAoDQXBMViH5jJCN0bnPBfrX4l%2Bykvv7zHpE55PL0aFQmQN%2BO8iPOY%2BymhDIJSglvV63y9qqjcOR34D6vr5q9UQmEzD2r2ZHKKXKD1IUtiXTseH1VnUkSEXIYZ7kxLrC13vgdrsFoOqnC17lxsNAsJBR9Rf6xmoB%2FTsZF2R4qqfHQ5PWXCbRERdx4xhPBqcP9urixcIq%2BtGRElje8yPoxv3I4pC6TKKoE96Cu1RN%2FeaVj79GqTSP2aabEnkAedX5FYDYCUPsdPODeZe4nHOywsDbJIoh2rCy8r0yTEYAMZ2yc2ereefM7Z6Tr4bn1nMk96oER%2B%2BQ7Q%2BHTS%2FBgVoTkQ2xovw22j5HOCAf1cZBNx7%2BX0CFMfk91vAkLzEjfJoxEBJQn3RNXp7lplXO8IqoDJK5A1mbAAA3j%2Bd%2B4tg385pvZfADmKrGJn51dsZrA3yFoYHo0AtAZS1NycjSIdjuHjQ6xg1ZJpdyrntx%2FAYmPX2QSkeltTO%2BYt%2B9EH2aE7EzvXkDDZPo5OWdgrzLYmo3O%2BOM3vmnDTKnYkKzFOJwww68zazAY6mAHKkZKOrnwUgNNKet3caXydfSxIvJGyL%2BhwxdiDLKobUbbU2%2FmslpHM1ARUFjghzs685sH%2BfdFkp7voGPKpngnm%2F8d7yNkslo0KCku2Hk%2FWFBHIdDHWagxjR4bJ3cEO1TjUEWkeI9Q6fwgwdaddmBKaqQ1ExPV2%2Fui9BniRN1Xi5VEjbWw%2ByzCoPHUvKSmEWfbYMhgegCvuXA%3D%3D&Expires=1771484596) - img srchttpsr2cdn.perplexity.aipplx-full-logo-primary-dark402x.png styleheight64pxmargin-right32px

